Federated Hermes’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-582
| Closed | -$605 | – | 2091 |
|
2024
Q3 | $605 | Buy |
+582
| New | +$605 | ﹤0.01% | 1990 |
|
2022
Q4 | – | Sell |
-4,223
| Closed | -$41K | – | 2177 |
|
2022
Q3 | $41K | Buy |
4,223
+1,498
| +55% | +$14.5K | ﹤0.01% | 1696 |
|
2022
Q2 | $20K | Sell |
2,725
-2,214
| -45% | -$16.3K | ﹤0.01% | 1763 |
|
2022
Q1 | $64K | Buy |
4,939
+708
| +17% | +$9.17K | ﹤0.01% | 1709 |
|
2021
Q4 | $68K | Sell |
4,231
-6,900
| -62% | -$111K | ﹤0.01% | 1753 |
|
2021
Q3 | $179K | Buy |
+11,131
| New | +$179K | ﹤0.01% | 1680 |
|
2021
Q2 | – | Sell |
-161
| Closed | -$2K | – | 2219 |
|
2021
Q1 | $2K | Sell |
161
-49,905
| -100% | -$620K | ﹤0.01% | 2115 |
|
2020
Q4 | $870K | Buy |
50,066
+425
| +0.9% | +$7.39K | ﹤0.01% | 1371 |
|
2020
Q3 | $910K | Buy |
+49,641
| New | +$910K | ﹤0.01% | 1267 |
|
2019
Q4 | – | Sell |
-329,979
| Closed | -$6.69M | – | 2221 |
|
2019
Q3 | $6.69M | Sell |
329,979
-227,259
| -41% | -$4.6M | 0.02% | 687 |
|
2019
Q2 | $12.3M | Buy |
+557,238
| New | +$12.3M | 0.03% | 506 |
|
2019
Q1 | – | Sell |
-1,348
| Closed | -$12K | – | 2154 |
|
2018
Q4 | $12K | Sell |
1,348
-134,723
| -99% | -$1.2M | ﹤0.01% | 1845 |
|
2018
Q3 | $2.25M | Buy |
136,071
+82,334
| +153% | +$1.36M | 0.01% | 1048 |
|
2018
Q2 | $752K | Buy |
53,737
+52,226
| +3,456% | +$731K | ﹤0.01% | 1365 |
|
2018
Q1 | $17K | Buy |
1,511
+80
| +6% | +$900 | ﹤0.01% | 1784 |
|
2017
Q4 | $13K | Sell |
1,431
-38
| -3% | -$345 | ﹤0.01% | 1831 |
|
2017
Q3 | $20K | Buy |
+1,469
| New | +$20K | ﹤0.01% | 1750 |
|
2016
Q1 | – | Sell |
-284,000
| Closed | -$6.52M | – | 2108 |
|
2015
Q4 | $6.52M | Sell |
284,000
-126,200
| -31% | -$2.9M | 0.02% | 514 |
|
2015
Q3 | $8.22M | Hold |
410,200
| – | – | 0.03% | 466 |
|
2015
Q2 | $11.9M | Buy |
+410,200
| New | +$11.9M | 0.04% | 433 |
|